ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
Tóm tắt
Từ khóa
Tài liệu tham khảo
Peyrin-Biroulet, 2015, Selecting Therapeutic Targets in Inflammatory Bowel Disease [STRIDE]: determining therapeutic goals for treat-to-target, Am J Gastroenterol, 110, 1324, 10.1038/ajg.2015.233
Dignass, 2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: definitions and diagnosis, J Crohns Colitis, 6, 965, 10.1016/j.crohns.2012.09.003
Turner, 2007, Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study, Gastroenterology, 133, 423, 10.1053/j.gastro.2007.05.029
Higgins, 2005, Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis, Gut, 54, 782, 10.1136/gut.2004.056358
Schroeder, 1987, Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, N Engl J Med, 317, 1625, 10.1056/NEJM198712243172603
Sutherland, 1987, 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis, Gastroenterology, 92, 1894, 10.1016/0016-5085(87)90621-4
D’Haens, 2007, A review of activity indexes and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038
Lewis, 2008, Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis, Inflamm Bowel Dis, 14, 1660, 10.1002/ibd.20520
Turner, 2009, A systematic prospective comparison of noninvasive disease activity indexes in ulcerative colitis, Clin Gastroenterol Hepatol, 7, 1081, 10.1016/j.cgh.2009.06.024
Truelove, 1955, Cortisone in ulcerative colitis; final report on a therapeutic trial, Br Med J, 2, 1041, 10.1136/bmj.2.4947.1041
Lichtiger, 1994, Cyclosporine in severe ulcerative colitis refractory to steroid therapy, N Engl J Med, 330, 1841, 10.1056/NEJM199406303302601
Sandborn, 1994, Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index, Mayo Clin Proc, 69, 409, 10.1016/S0025-6196(12)61634-6
Annese, 2013, European evidence-based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016
Neurath, 2012, Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, 61, 1619, 10.1136/gutjnl-2012-302830
Frøslie, 2007, Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort, Gastroenterology, 133, 412, 10.1053/j.gastro.2007.05.051
Ardizzone, 2006, Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis, Gut, 55, 47, 10.1136/gut.2005.068809
Colombel, 2011, Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis, Gastroenterology, 141, 1194, 10.1053/j.gastro.2011.06.054
Rutter, 2004, Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, 126, 451, 10.1053/j.gastro.2003.11.010
Baron, 1964, Variation between observers in describing mucosal appearances in proctocolitis, Br Med J, 1, 89, 10.1136/bmj.1.5375.89
Feagan, 2005, Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin, N Engl J Med, 352, 2499, 10.1056/NEJMoa042982
Feagan, 2013, The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis, Gastroenterology, 145, 149, 10.1053/j.gastro.2013.03.025
Powell-Tuck, 1978, A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis, Scand J Gastroenterol, 13, 833, 10.3109/00365527809182199
Rachmilewitz, 1989, Coated mesalazine [5-aminosalicylic acid] versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial, BMJ, 298, 82, 10.1136/bmj.298.6666.82
Lobatón, 2015, The Modified Mayo Endoscopic Score [MMES]: a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients, J Crohns Colitis, 9, 846, 10.1093/ecco-jcc/jjv111
Travis, 2013, Reliability and initial validation of the ulcerative colitis endoscopic index of severity, Gastroenterology, 145, 987, 10.1053/j.gastro.2013.07.024
Ikeya, 2016, The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo Endoscopic Score, J Crohns Colitis, 10, 286, 10.1093/ecco-jcc/jjv210
Saigusa, 2016, Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab, Dig Endosc, 28, 665, 10.1111/den.12655
Corte, 2015, Association between the ulcerative colitis endoscopic index of severity [UCEIS] and outcomes in acute severe ulcerative colitis, J Crohns Colitis, 9, 376, 10.1093/ecco-jcc/jjv047
Arai, 2016, The Ulcerative Colitis Endoscopic Index Of Severity is useful to predict medium- to long-term prognosis in ulcerative colitis patients with clinical remission, J Crohns Colitis, 10, 1303, 10.1093/ecco-jcc/jjw104
Travis, 2015, The impact of clinical information on the assessment of endoscopic activity: characteristics of the Ulcerative Colitis Endoscopic Index of Severity [UCEIS], J Crohns Colitis, 9, 607, 10.1093/ecco-jcc/jjv077
Colombel, 2016, Agreement between rectosigmoidoscopy and colonoscopy analyses of disease activity and healing in patients with ulcerative colitis, Gastroenterology, 150, 389, 10.1053/j.gastro.2015.10.016
Samuel, 2013, Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures, Clin Gastroenterol Hepatol, 11, 49, 10.1016/j.cgh.2012.08.003
D’Incà, 2014, Measuring disease activity in Crohn’s disease: what is currently available to the clinician, Clin Exp Gastroenterol, 7, 151, 10.2147/CEG.S41413
Gomollón, 2017, Third European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016. Part 1: diagnosis and medical management, J Crohns Colitis, 11, 3, 10.1093/ecco-jcc/jjw168
Best, 1976, Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study, Gastroenterology, 70, 439, 10.1016/S0016-5085(76)80163-1
Harvey, 1980, A simple index of Crohn’s-disease activity, Lancet, 1, 514, 10.1016/S0140-6736(80)92767-1
Papay, 2013, Optimising monitoring in the management of Crohn’s disease: a physician’s perspective, J Crohns Colitis, 7, 653, 10.1016/j.crohns.2013.02.005
Sostegni, 2003, Review article: Crohn’s disease: monitoring disease activity, Aliment Pharmacol Ther, 17, 11, 10.1046/j.1365-2036.17.s2.17.x
Solem, 2005, Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease, Inflamm Bowel Dis, 11, 707, 10.1097/01.MIB.0000173271.18319.53
Pariente, 2011, Development of the Crohn’s disease digestive damage score, the Lémann score, Inflamm Bowel Dis, 17, 1415, 10.1002/ibd.21506
Irvine, 1995, Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group, J Clin Gastroenterol, 20, 27, 10.1097/00004836-199501000-00008
Pikarsky, 2002, Perianal Crohn disease: a new scoring system to evaluate and predict outcome of surgical intervention, Arch Surg, 137, 774, 10.1001/archsurg.137.7.774
Mary, 1989, Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif [GETAID], Gut, 30, 983, 10.1136/gut.30.7.983
Daperno, 2004, Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD, Gastrointest Endosc, 60, 505, 10.1016/S0016-5107(04)01878-4
Rutgeerts, 1990, Predictability of the postoperative course of Crohn’s disease, Gastroenterology, 99, 956, 10.1016/0016-5085(90)90613-6
De Cruz, 2013, Mucosal healing in Crohn’s disease: a systematic review, Inflamm Bowel Dis, 19, 429, 10.1002/ibd.22977
Niv, 2012, Validation of the Capsule Endoscopy Crohn’s Disease Activity Index [CECDAI or Niv score]: a multicenter prospective study, Endoscopy, 44, 21, 10.1055/s-0031-1291385
Gralnek, 2008, Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change, Aliment Pharmacol Ther, 27, 146, 10.1111/j.1365-2036.2007.03556.x
Stange, 2008, European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis, J Crohns Colitis, 2, 1, 10.1016/j.crohns.2007.11.001
Van Assche, 2010, The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis, J Crohns Colitis, 4, 7, 10.1016/j.crohns.2009.12.003
Langner, 2014, The histopathological approach to inflammatory bowel disease: a practice guide, Virchows Arch, 464, 511
Magro, 2013, European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 7, 827, 10.1016/j.crohns.2013.06.001
Bryant, 2016, Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up, Gut, 65, 408, 10.1136/gutjnl-2015-309598
Marchal-Bressenot, 2017, Development and validation of the Nancy histological index for UC, Gut, 66, 43, 10.1136/gutjnl-2015-310187
Price, 1975, Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis, Hum Pathol, 6, 7, 10.1016/S0046-8177(75)80107-9
Moum, 1999, Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time, Am J Gastroenterol, 94, 1564, 10.1111/j.1572-0241.1999.01145.x
Levine, 1996, Diagnostic difficulty arising from rectal recovery in ulcerative colitis, J Clin Pathol, 49, 319, 10.1136/jcp.49.4.319
Bryant, 2014, Systematic review: histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative, J Crohns Colitis, 8, 1582, 10.1016/j.crohns.2014.08.011
Hefti, 2009, Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis, Dis Colon Rectum, 52, 193, 10.1007/DCR.0b013e31819ad456
Rubin D, Huo D, Hetzel J, Bunnag A, Sedrak M, Hart J. Increased degree of histological inflammation predicts colectomy and hospitalization in patients with ulcerative colitis. Gastroenterology 2012;132(S1):A19
Lichtenstein, 2010, Importance of mucosal healing in ulcerative colitis, Inflamm Bowel Dis, 16, 338, 10.1002/ibd.20997
Bryant, 2014, Systematic review: histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative, J Crohns Colitis, 8, 1582, 10.1016/j.crohns.2014.08.011
Peyrin–Biroulet, 2014, Histologic remission: the ultimate therapeutic goal in ulcerative colitis, Clin Gastroenterol Hepatol, 12, 929, 10.1016/j.cgh.2013.07.022
Mosli, 2014, Histologic evaluation of ulcerative colitis: a systematic review of disease activity indexes, Inflamm Bowel Dis, 20, 564, 10.1097/01.MIB.0000437986.00190.71
Riley, 1991, Microscopic activity in ulcerative colitis: what does it mean, Gut, 32, 174, 10.1136/gut.32.2.174
Geboes, 2000, A reproducible grading scale for histological assessment of inflammation in ulcerative colitis, Gut, 47, 404, 10.1136/gut.47.3.404
Mosli, 2017, Development and validation of a histological index for UC, Gut, 66, 50, 10.1136/gutjnl-2015-310393
Panés, 2011, Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease, Aliment Pharmacol Ther, 34, 125, 10.1111/j.1365-2036.2011.04710.x
Rimola, 2012, Imaging indexes of activity and severity for Crohn’s disease: current status and future trends, Abdom Imaging, 37, 958, 10.1007/s00261-011-9820-z
Coimbra, 2016, Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn’s disease, and may help select subjects with active inflammation, Aliment Pharmacol Ther, 43, 61, 10.1111/apt.13453
Ordás, 2014, Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease, Gastroenterology, 146, 374, 10.1053/j.gastro.2013.10.055
Takenaka, 2015, Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn’s disease, Inflamm Bowel Dis, 21, 1832, 10.1097/MIB.0000000000000449
Ordás, 2014, Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease, Gastroenterology, 146, 374, 10.1053/j.gastro.2013.10.055
Stoppino, 2016, Magnetic resonance enterography changes after antibody to tumor necrosis factor [anti-TNF] alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers, BMC Med Imaging, 16, 37, 10.1186/s12880-016-0139-7
Steward, 2012, Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index, Eur J Radiol, 81, 2080, 10.1016/j.ejrad.2011.07.013
Tielbeek, 2013, Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity, AJR Am J Roentgenol, 201, 1220, 10.2214/AJR.12.10341
Rimola, 2017, Comparison of three magnetic resonance enterography indexes for grading activity in Crohn’s disease, J Gastroenterol, 52, 585, 10.1007/s00535-016-1253-6
Buisson, 2013, Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease, Aliment Pharmacol Ther, 37, 537, 10.1111/apt.12201
Hordonneau, 2014, Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity, Am J Gastroenterol, 109, 89, 10.1038/ajg.2013.385
Rimola, 2009, Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease, Gut, 58, 1113, 10.1136/gut.2008.167957
Sailer, 2008, Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy, Eur Radiol, 18, 2512, 10.1007/s00330-008-1034-6
Dohan, 2016, Diffusion-weighted MRI in Crohn’s disease: Current status and recommendations, J Magn Reson Imaging, 44, 1381, 10.1002/jmri.25325
Van Assche, 2003, Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease, Am J Gastroenterol, 98, 332, 10.1016/S0002-9270(02)05909-9
Horsthuis, 2009, Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity, Radiology, 251, 380, 10.1148/radiol.2512072128
Karmiris, 2011, Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging, Clin Gastroenterol Hepatol, 9, 130, 10.1016/j.cgh.2010.10.022
Ng, 2009, Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas, Am J Gastroenterol, 104, 2973, 10.1038/ajg.2009.509
Horsthuis, 2011, Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn’s disease, Clin Imaging, 35, 360, 10.1016/j.clinimag.2010.09.003
Samaan, 2017, The development of a magnetic resonance imaging index for fistulising Crohn’s disease, Aliment Pharmacol Ther, 46, 516, 10.1111/apt.14190
Savoye-Collet, 2011, Fistulizing perianal Crohn’s disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy, Inflamm Bowel Dis, 17, 1751, 10.1002/ibd.21568
Pariente, 2015, Development of the Lémann index to assess digestive tract damage in patients with Crohn’s disease, Gastroenterology, 148, 52, 10.1053/j.gastro.2014.09.015
Fiorino, 2015, Bowel damage as assessed by the lémann index is reversible on anti-TNF therapy for Crohn’s disease, J Crohns Colitis, 9, 633, 10.1093/ecco-jcc/jjv080
Gilletta, 2015, Changes in the Lémann index values during the first years of Crohn’s disease, Clin Gastroenterol Hepatol, 13, 1633, 10.1016/j.cgh.2015.02.041
Rispo, 2017, Bowel damage in Crohn’s disease: direct comparison of ultrasonography-based and magnetic resonance-based Lemann index, Inflamm Bowel Dis, 23, 143, 10.1097/MIB.0000000000000980
Rimola, 2011, Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, 17, 1759, 10.1002/ibd.21551
Steward, 2012, Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index, Eur J Radiol, 81, 2080, 10.1016/j.ejrad.2011.07.013
Becker, 2015, Living with inflammatory bowel disease: a Crohn’s and Colitis Canada survey, Can J Gastroenterol Hepatol, 29, 77, 10.1155/2015/815820
Alrubaiy, 2015, Systematic review of health-related quality of life measures for inflammatory bowel disease, J Crohns Colitis, 9, 284, 10.1093/ecco-jcc/jjv002
Williet, 2014, Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease, Clin Gastroenterol Hepatol, 12, 1246, 10.1016/j.cgh.2014.02.016
Grad, 2002, The Preamble of the Constitution of the World Health Organization, Bull World Health Organ, 80, 981
El-Matary, 2014, Patient-reported outcome measures in inflammatory bowel disease, Can J Gastroenterol Hepatol, 28, 536, 10.1155/2014/792386
Zand, 2015, Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact, Inflamm Bowel Dis, 21, 1623, 10.1097/MIB.0000000000000399
Zahn, 2006, Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis, Inflamm Bowel Dis, 12, 1058, 10.1097/01.mib.0000234134.35713.d2
Øresland, 2015, European evidence-based consensus on surgery for ulcerative colitis, J Crohns Colitis, 9, 4, 10.1016/j.crohns.2014.08.012
Williet, 2017, Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients, J Crohns Colitis, 11, 165, 10.1093/ecco-jcc/jjw145
Guyatt, 1989, A new measure of health status for clinical trials in inflammatory bowel disease, Gastroenterology, 96, 804, 10.1016/0016-5085(89)90905-0
Dibley, 2016, Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: the ICIQ-IBD, Eur J Gastroenterol Hepatol, 28, 233, 10.1097/MEG.0000000000000513
Mantzouranis, 2015, Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past 10 years, J Crohns Colitis, 9, 1160, 10.1093/ecco-jcc/jjv140
Hughes, 2016, Food-related quality of life in inflammatory bowel disease: development and validation of a questionnaire, J Crohns Colitis, 10, 194, 10.1093/ecco-jcc/jjv192
Huppertz-Hauss, 2017, Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study, Scand J Gastroenterol, 52, 351, 10.1080/00365521.2016.1256425
Gower-Rousseau, 2017, Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort, Gut, 66, 588, 10.1136/gutjnl-2015-310151
Bernklev, 2005, Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms, Inflamm Bowel Dis, 11, 909, 10.1097/01.mib.0000179467.01748.99
Hoivik, 2010, Need for standardization in population-based quality of life studies: a review of the current literature, Inflamm Bowel Dis, 16, 525, 10.1002/ibd.21032
Ravens-Sieberer, 2005, KIDSCREEN-52 quality-of-life measure for children and adolescents, Expert Rev Pharmacoecon Outcomes Res, 5, 353, 10.1586/14737167.5.3.353
Griffiths, 1999, Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type, J Pediatr Gastroenterol Nutr, 28, S46, 10.1097/00005176-199904001-00009
Kunz, 2011, Maternal, paternal, and family health-related quality of life in the context of pediatric inflammatory bowel disease, Qual Life Res, 20, 1197, 10.1007/s11136-011-9853-3
Maunder, 1995, Effect of intervention in inflammatory bowel disease on health-related quality of life: a critical review, Dis Colon Rectum, 38, 1147, 10.1007/BF02048330
Irvine, 1996, The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators: Canadian Crohn’s Relapse Prevention Trial, Am J Gastroenterol, 91, 1571
Chen, 2017, Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties, Health Qual Life Outcomes, 15, 177, 10.1186/s12955-017-0753-2
McDermott, 2013, The Short Health Scale: a valid and reliable measure of health-related quality of life in English-speaking inflammatory bowel disease patients, J Crohns Colitis, 7, 616, 10.1016/j.crohns.2012.07.030
Park, 2017, Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease, World J Gastroenterol, 23, 3530, 10.3748/wjg.v23.i19.3530
Jelsness-Jørgensen, 2012, Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale [SHS], Qual Life Res, 21, 1671, 10.1007/s11136-011-0081-7
Abdovic, 2015, Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease, Inflamm Bowel Dis, 21, 818, 10.1097/MIB.0000000000000324
Krarup, 2015, The short health scale: a simple, valid, reliable, and responsive way of measuring subjective health in patients with irritable bowel syndrome, J Clin Gastroenterol, 49, 565, 10.1097/MCG.0000000000000209
Feagan, 2009, Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn’s disease, Am J Gastroenterol, 104, 1976, 10.1038/ajg.2009.199
D’Haens, 2007, A review of activity indexes and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038
Stark, 2010, Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany, Inflamm Bowel Dis, 16, 42, 10.1002/ibd.20989
Alrubaiy, 2015, Development of a short questionnaire to assess the quality of life in Crohn’s disease and ulcerative colitis, J Crohns Colitis, 9, 66, 10.1093/ecco-jcc/jju005
Kaminski, 2017, Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy [ESGE] quality improvement initiative, United European Gastroenterol J, 5, 309, 10.1177/2050640617700014
Panes, 2017, Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases, Gastroenterology, 152, 362, 10.1053/j.gastro.2016.10.005
Terheggen, 2008, Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease, Endoscopy, 40, 656, 10.1055/s-2008-1077445
Shingina, 2016, Identification of factors associated with sedation tolerance in 5000 patients undergoing outpatient colonoscopy: Canadian tertiary center experience, World J Gastrointest Endosc, 8, 770, 10.4253/wjge.v8.i20.770
Ferreira, 2015, Sedation in gastrointestinal endoscopy: Where are we at in 2014, World J Gastrointest Endosc, 7, 102, 10.4253/wjge.v7.i2.102
Conigliaro, 2017, Italian Society of Digestive Endoscopy [SIED] position paper on the non-anaesthesiologist administration of propofol for gastrointestinal endoscopy, Dig Liver Dis, 49, 1185, 10.1016/j.dld.2017.08.038
Dumonceau, 2015, Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline–Updated June 2015, Endoscopy, 47, 1175, 10.1055/s-0034-1393414
Memon, 2016, Carbon dioxide versus air insufflation for elective colonoscopy: a meta-analysis and systematic review of randomized controlled trials, Surg Laparosc Endosc Percutan Tech, 26, 102, 10.1097/SLE.0000000000000243
Mathus-Vliegen, 2013, Consensus guidelines for the use of bowel preparation prior to colonic diagnostic procedures: colonoscopy and small bowel video capsule endoscopy, Curr Med Res Opin, 29, 931, 10.1185/03007995.2013.803055
Kilgore, 2011, Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials, Gastrointest Endosc, 73, 1240, 10.1016/j.gie.2011.02.007
Martel, 2015, Split-dose preparations are superior to day-before bowel cleansing regimens: a meta-analysis, Gastroenterology, 149, 79, 10.1053/j.gastro.2015.04.004
Nett, 2014, Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must, Gastrointest Endosc Clin N Am, 24, 379, 10.1016/j.giec.2014.03.004
Manes, 2015, Colon cleansing for colonoscopy in patients with ulcerative colitis: efficacy and acceptability of a 2-L PEG plus Bisacodyl versus 4-L PEG, Inflamm Bowel Dis, 21, 2137, 10.1097/MIB.0000000000000463
Hassan, 2013, Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy [ESGE] guideline, Endoscopy, 45, 142, 10.1055/s-0032-1326186
Laine, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastrointest Endosc, 81, 489, 10.1016/j.gie.2014.12.009
Chen, 2015, Endoscopic therapy in Crohn’s disease: principle, preparation, and technique, Inflamm Bowel Dis, 21, 2222, 10.1097/MIB.0000000000000433
Marion, 2008, Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial, Am J Gastroenterol, 103, 2342, 10.1111/j.1572-0241.2008.01934.x
Har-Noy, 2017, Chromoendoscopy, narrow-band imaging or white light endoscopy for neoplasia detection in inflammatory bowel diseases, Dig Dis Sci, 62, 2982, 10.1007/s10620-017-4772-y
Collins, 2016, Video capsule endoscopy in inflammatory bowel disease, World J Gastrointest Endosc, 8, 477, 10.4253/wjge.v8.i14.477
Han, 2016, Colon capsule endoscopy: where are we and where are we going, Clin Endosc, 49, 449, 10.5946/ce.2016.095
Boal Carvalho, 2015, PillCam COLON 2 in Crohn’s disease: a new concept of pan-enteric mucosal healing assessment, World J Gastroenterol, 21, 7233, 10.3748/wjg.v21.i23.7233
Enns, 2017, Clinical practice guidelines for the use of video capsule endoscopy, Gastroenterology, 152, 497, 10.1053/j.gastro.2016.12.032
Gal, 2008, Assessment and validation of the new capsule endoscopy Crohn’s disease activity index [CECDAI], Dig Dis Sci, 53, 1933, 10.1007/s10620-007-0084-y
Rezapour, 2017, Retention associated with video capsule endoscopy: systematic review and meta-analysis, Gastrointest Endosc, 85, 1157, 10.1016/j.gie.2016.12.024
Perez-Cuadrado, 1997, Usefulness or oral video push enteroscopy in Crohn’s disease, Endoscopy, 29, 745, 10.1055/s-2007-1004300
Pennazio, 2015, Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy [ESGE] Clinical Guideline, Endoscopy, 47, 352, 10.1055/s-0034-1391855
Saygili, 2015, Examining the whole bowel, double balloon enteroscopy: Indications, diagnostic yield and complications, World J Gastrointest Endosc, 7, 247, 10.4253/wjge.v7.i3.247
Arulanandan, 2016, Systematic review: safety of balloon assisted enteroscopy in Crohn’s disease, World J Gastroenterol, 22, 8999, 10.3748/wjg.v22.i40.8999
Li, 2014, Carbon dioxide insufflation improves the intubation depth and total enteroscopy rate in single-balloon enteroscopy: a randomised, controlled, double-blind trial, Gut, 63, 1560, 10.1136/gutjnl-2013-306069
Lenz, 2014, CO2 insufflation during single-balloon enteroscopy: a multicenter randomized controlled trial, Endoscopy, 46, 53
Marshall, 2004, Prospective comparison of small bowel meal with pneumocolon versus ileo-colonoscopy for the diagnosis of ileal Crohn’s disease, Am J Gastroenterol, 99, 1321, 10.1111/j.1572-0241.2004.30499.x
Pickhardt, 2012, The peroral pneumocolon revisited: a valuable fluoroscopic and CT technique for ileocecal evaluation, Abdom Imaging, 37, 313, 10.1007/s00261-011-9766-1
Maglinte, 1987, Small bowel radiography: how, when, and why, Radiology, 163, 297, 10.1148/radiology.163.2.3550876
Sellink, 1974, Radiologic examination of the small intestine by duodenal intubation, Acta Radiol Diagn [Stockh], 15, 318, 10.1177/028418517401500310
Herlinger, 1978, A modified technique for the double-contrast small bowel enema, Gastrointest Radiol, 3, 201, 10.1007/BF01887065
Thoeni, 1991, Enteroclysis and small bowel series: comparison of radiation dose and examination time, Radiology, 178, 659, 10.1148/radiology.178.3.1994398
Jaffe, 2007, Radiation doses from small-bowel follow-through and abdominopelvic MDCT in Crohn’s disease, AJR Am J Roentgenol, 189, 1015, 10.2214/AJR.07.2427
Gaca, 2008, Radiation doses from small-bowel follow-through and abdomen/pelvis MDCT in pediatric Crohn disease, Pediatr Radiol, 38, 285, 10.1007/s00247-007-0702-z
Frederick-Dyer, 2013, Online training on the safe use of fluoroscopy can result in a significant decrease in patient dose, Acad Radiol, 20, 1272, 10.1016/j.acra.2013.07.008
Bibbo, 2016, Diagnostic reference levels for common paediatric fluoroscopic examinations performed at a dedicated paediatric Australian hospital, J Med Imaging Radiat Oncol, 60, 469, 10.1111/1754-9485.12478
Taylor, 2017, The first joint ESGAR/ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging, Eur Radiol, 27, 2570, 10.1007/s00330-016-4615-9
Fiorino, 2013, Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease, Dig Dis Sci, 58, 3246, 10.1007/s10620-013-2781-z
Jiang, 2014, MR imaging of distal ileal and colorectal chronic inflammatory bowel disease–diagnostic accuracy of 1.5 T and 3 T MRI compared to colonoscopy, Int J Colorectal Dis, 29, 1541, 10.1007/s00384-014-2037-1
Jesuratnam-Nielsen, 2015, Diagnostic accuracy of three different MRI protocols in patients with inflammatory bowel disease, Acta Radiol Open, 4, 2058460115588099
Jesuratnam-Nielsen, 2015, Plain magnetic resonance imaging as an alternative in evaluating inflammation and bowel damage in inflammatory bowel disease–a prospective comparison with conventional magnetic resonance follow-through, Scand J Gastroenterol, 50, 519, 10.3109/00365521.2014.1003398
Borthne, 2006, Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging, Eur Radiol, 16, 1331, 10.1007/s00330-005-0063-7
Ippolito, 2010, MR enterography with polyethylene glycol as oral contrast medium in the follow-up of patients with Crohn disease: comparison with CT enterography, Abdom Imaging, 35, 563, 10.1007/s00261-009-9557-0
Ajaj, 2004, Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension, Eur Radiol, 14, 458, 10.1007/s00330-003-2177-0
Ajaj, 2004, Dose optimization of mannitol solution for small bowel distension in MRI, J Magn Reson Imaging, 20, 648, 10.1002/jmri.20166
Maccioni, 2002, MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents, Abdom Imaging, 27, 384, 10.1007/s00261-001-0119-3
Laghi, 2003, MR of the small bowel with a biphasic oral contrast agent [polyethylene glycol]: technical aspects and findings in patients affected by Crohn’s disease, Radiol Med, 106, 18
Evrimler, 2016, MR enterography with oral contrast agent composed of methylcellulose, low-dose barium sulfate, sorbitol, and lactulose: assessment of diagnostic performance, reliability, image quality, and patient tolerance, Clin Imaging, 40, 523, 10.1016/j.clinimag.2016.01.002
Maccioni, 2010, Double-contrast magnetic resonance imaging of the small and large bowel: effectiveness in the evaluation of inflammatory bowel disease, Abdom Imaging, 35, 31, 10.1007/s00261-008-9482-7
Bekendam, 2017, Shortened oral contrast preparation for improved small bowel distension at MR enterography, Abdom Radiol [NY], 42, 2225, 10.1007/s00261-017-1133-4
Kuehle, 2006, Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention, AJR Am J Roentgenol, 187, W375, 10.2214/AJR.05.1079
Negaard, 2008, MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn’s disease: randomized comparison of patient acceptance, Scand J Gastroenterol, 43, 44, 10.1080/00365520701494813
Minordi, 2011, CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease, Br J Radiol, 84, 112, 10.1259/bjr/71649888
Minordi, 2016, Enterography CT without and with water enema in patients with Crohn’s disease: Results from a comparative observational study in comparison with endoscopy, Eur J Radiol, 85, 404, 10.1016/j.ejrad.2015.11.028
Cronin, 2010, Does MRI with oral contrast medium allow single-study depiction of inflammatory bowel disease enteritis and colitis, Eur Radiol, 20, 1667, 10.1007/s00330-009-1701-2
Friedrich, 2012, Magnetic resonance enterography with and without biphasic contrast agent enema compared to conventional ileocolonoscopy in patients with Crohn’s disease, Inflamm Bowel Dis, 18, 1842, 10.1002/ibd.22843
Cronin, 2008, MRI small-bowel follow-through: prone versus supine patient positioning for best small-bowel distention and lesion detection, AJR Am J Roentgenol, 191, 502, 10.2214/AJR.07.2338
Vandenbroucke, 2007, Noninvasive multidetector computed tomography enterography in patients with small-bowel Crohn’s disease: is a 40-second delay better than 70 seconds, Acta Radiol, 48, 1052, 10.1080/02841850701589290
Huprich, 2009, CT enterography: principles, technique and utility in Crohn’s disease, Eur J Radiol, 69, 393, 10.1016/j.ejrad.2008.11.014
Baker, 2015, CT enterography for Crohn’s disease: optimal technique and imaging issues, Abdom Imaging, 40, 938, 10.1007/s00261-015-0357-4
Young, 2013, Predictors of excessive CT scan use in a surgical cohort of patients with Crohn’s disease, Postgrad Med, 125, 94, 10.3810/pgm.2013.11.2716
Desmond, 2008, Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation, Gut, 57, 1524, 10.1136/gut.2008.151415
Guimarães, 2010, Feasibility of dose reduction using novel denoising techniques for low kV [80 kV] CT enterography: optimization and validation, Acad Radiol, 17, 1203, 10.1016/j.acra.2010.07.001
Camera, 2017, Diagnostic efficacy of single-pass abdominal multidetector-row CT: prospective evaluation of a low dose protocol, Br J Radiol, 90, 20160612, 10.1259/bjr.20160612
Lee, 2011, Comparison of image quality and radiation dose between combined automatic tube current modulation and fixed tube current technique in CT of abdomen and pelvis, Acta Radiol, 52, 1101, 10.1258/ar.2011.100295
Gandhi, 2016, Diagnostic accuracy of CT enterography for active inflammatory terminal ileal Crohn disease: comparison of full-dose and half-dose images reconstructed with FBP and half-dose images with SAFIRE, Radiology, 280, 436, 10.1148/radiol.2016151281
Murphy, 2015, Model-based iterative reconstruction in CT enterography, AJR Am J Roentgenol, 205, 1173, 10.2214/AJR.14.13321
Murphy, 2015, The role of pure iterative reconstruction in conventional dose CT enterography, Abdom Imaging, 40, 251, 10.1007/s00261-014-0222-x
McLaughlin, 2016, Pure iterative reconstruction improves image quality in computed tomography of the abdomen and pelvis acquired at substantially reduced radiation doses in patients with active Crohn disease, J Comput Assist Tomogr, 40, 225, 10.1097/RCT.0000000000000358
Kaza, 2012, CT enterography at 80 kVp with adaptive statistical iterative reconstruction versus at 120 kVp with standard reconstruction: image quality, diagnostic adequacy, and dose reduction, AJR Am J Roentgenol, 198, 1084, 10.2214/AJR.11.6597
Grand, 2012, Detection of Crohn’s disease: Comparison of CT and MR enterography without anti-peristaltic agents performed on the same day, Eur J Radiol, 81, 1735, 10.1016/j.ejrad.2011.04.068
Gutzeit, 2012, Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration, Eur Radiol, 22, 1186, 10.1007/s00330-011-2366-1
Maccioni, 2006, MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent, Radiology, 238, 517, 10.1148/radiol.2381040244
Low, 2002, Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging, Radiology, 222, 652, 10.1148/radiol.2223010811
Radbruch, 2015, Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent, Radiology, 275, 783, 10.1148/radiol.2015150337
Roberts, 2016, Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent, AJNR Am J Neuroradiol, 37, 2340, 10.3174/ajnr.A4891
Kanda, 2016, Recent advances in understanding gadolinium retention in the brain, AJNR Am J Neuroradiol, 37, E1, 10.3174/ajnr.A4586
Kahn, 2017, Is there long-term signal intensity increase in the central nervous system on T1-weighted images after MR imaging with the hepatospecific contrast agent gadoxetic acid? A cross-sectional study in 91 patients, Radiology, 282, 708, 10.1148/radiol.2016162535
Quaia, 2016, Impact of gadolinium-based contrast agent in the assessment of Crohn’s disease activity: Is contrast agent injection necessary, J Magn Reson Imaging, 43, 688, 10.1002/jmri.25024
Seo, 2016, MR enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study, Radiology, 278, 762, 10.1148/radiol.2015150809
Kim, 2015, Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography, Inflamm Bowel Dis, 21, 101, 10.1097/MIB.0000000000000222
Sirin, 2015, Magnetic resonance colonography including diffusion-weighted imaging in children and adolescents with inflammatory bowel disease: do we really need intravenous contrast, Invest Radiol, 50, 32, 10.1097/RLI.0000000000000092
Shenoy-Bhangle, 2016, Value of diffusion-weighted imaging when added to magnetic resonance enterographic evaluation of Crohn disease in children, Pediatr Radiol, 46, 34, 10.1007/s00247-015-3438-1
Menys, 2013, Small bowel strictures in Crohn’s disease: a quantitative investigation of intestinal motility using MR enterography, Neurogastroenterol Motil, 25, 967, 10.1111/nmo.12229
Plumb, 2015, Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease, Aliment Pharmacol Ther, 42, 343, 10.1111/apt.13275
Hahnemann, 2015, Quantitative assessment of small bowel motility in patients with Crohn’s disease using dynamic MRI, Neurogastroenterol Motil, 27, 841, 10.1111/nmo.12558
Hahnemann, 2015, Improved detection of inflammatory bowel disease by additional automated motility analysis in magnetic resonance imaging, Invest Radiol, 50, 67, 10.1097/RLI.0000000000000097
Tolan, 2016, Magnetic resonance imaging for perianal fistula, Semin Ultrasound CT MR, 37, 313, 10.1053/j.sult.2016.04.004
Lo Re, 2016, MR imaging of perianal fistulas in Crohn’s disease: sensitivity and specificity of STIR sequences, Radiol Med, 121, 243, 10.1007/s11547-015-0603-4
Torkzad, 2014, Comparison of different magnetic resonance imaging sequences for assessment of fistula-in-ano, World J Radiol, 6, 203, 10.4329/wjr.v6.i5.203
Tielbeek, 2014, Training readers to improve their accuracy in grading Crohn’s disease activity on MRI, Eur Radiol, 24, 1059, 10.1007/s00330-014-3111-3
Puylaert, 2016, Long-term performance of readers trained in grading Crohn disease activity using MRI, Acad Radiol, 23, 1539, 10.1016/j.acra.2016.08.006
AlSabban, 2017, Accuracy and interobserver agreement of diffusion-weighted imaging in pediatric inflammatory bowel disease, Clin Imaging, 41, 14, 10.1016/j.clinimag.2016.09.007
Horvat, 2016, Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease, World J Gastroenterol, 22, 10002, 10.3748/wjg.v22.i45.10002
Jensen, 2011, Interobserver and intermodality agreement for detection of small bowel Crohn’s disease with MR enterography and CT enterography, Inflamm Bowel Dis, 17, 1081, 10.1002/ibd.21534
Buchanan, 2004, MRI of fistula in ano: inter- and intraobserver agreement and effects of directed education, AJR Am J Roentgenol, 183, 135, 10.2214/ajr.183.1.1830135
Fraquelli, 2005, Role of US in detection of Crohn disease: meta-analysis, Radiology, 236, 95, 10.1148/radiol.2361040799
Rompel, 2006, Harmonic US imaging of appendicitis in children, Pediatr Radiol, 36, 1257, 10.1007/s00247-006-0313-0
Ruess, 2000, Inflammatory bowel disease in children and young adults: correlation of sonographic and clinical parameters during treatment, AJR Am J Roentgenol, 175, 79, 10.2214/ajr.175.1.1750079
Ripollés, 2005, Sonographic findings in ischemic colitis in 58 patients, AJR Am J Roentgenol, 184, 777, 10.2214/ajr.184.3.01840777
Drews, 2009, Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease, Eur Radiol, 19, 1379, 10.1007/s00330-008-1290-5
Neye, 2004, Evaluation of criteria for the activity of Crohn’s disease by power Doppler sonography, Dig Dis, 22, 67, 10.1159/000078737
Wilson, 2010, Microbubble-enhanced US in body imaging: what role, Radiology, 257, 24, 10.1148/radiol.10091210
Migaleddu, 2009, Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease, Gastroenterology, 137, 43, 10.1053/j.gastro.2009.03.062
Medellin, 2018, Role of contrast-enhanced ultrasound in evaluation of the bowel, Abdom Radiol [NY], 43, 918, 10.1007/s00261-017-1399-6
Kratzer, 2005, Contrast-enhanced wideband harmonic imaging ultrasound [SonoVue]: a new technique for quantifying bowel wall vascularity in Crohn’s disease, Scand J Gastroenterol, 40, 985, 10.1080/00365520510015818
Nylund, 2013, Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn’s disease, Ultrasound Med Biol, 39, 1197, 10.1016/j.ultrasmedbio.2013.01.020
Romanini, 2014, Quantitative analysis of contrast-enhanced ultrasonography of the bowel wall can predict disease activity in inflammatory bowel disease, Eur J Radiol, 83, 1317, 10.1016/j.ejrad.2014.05.012
Ripollés, 2013, Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions, Eur J Radiol, 82, e525, 10.1016/j.ejrad.2013.05.043
Calabrese, 2012, Ultrasound in Crohn’s disease, Curr Drug Targets, 13, 1224, 10.2174/138945012802429697
Calabrese, 2013, Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn’s disease, Clin Gastroenterol Hepatol, 11, 950, 10.1016/j.cgh.2013.01.015
Rieder, 2013, Crohn’s disease complicated by strictures: a systematic review, Gut, 62, 1072, 10.1136/gutjnl-2012-304353
Quencer, 2013, Detecting active inflammation and fibrosis in pediatric Crohn’s disease: prospective evaluation of MR-E and CT-E, Abdom Imaging, 38, 705, 10.1007/s00261-013-9981-z
Ha, 2011, Magnetic resonance enterography: safe and effective imaging for stricturing Crohn’s disease, Dig Dis Sci, 56, 2906, 10.1007/s10620-011-1781-0
Ripollés, 2013, Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis, J Crohns Colitis, 7, 120, 10.1016/j.crohns.2012.03.002
Quaia, 2012, The value of small bowel wall contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn’s disease, Ultrasound Med Biol, 38, 1324, 10.1016/j.ultrasmedbio.2012.04.008
Ophir, 1991, Elastography: a quantitative method for imaging the elasticity of biological tissues, Ultrason Imaging, 13, 111, 10.1177/016173469101300201
Baumgart, 2015, US-based real-time elastography for the detection of fibrotic gut tissue in patients with stricturing Crohn disease, Radiology, 275, 889, 10.1148/radiol.14141929
Fraquelli, 2015, The role of ultrasound elasticity imaging in predicting ileal fibrosis in Crohn’s disease patients, Inflamm Bowel Dis, 21, 2605, 10.1097/MIB.0000000000000536
Nylund, 2017, EFSUMB recommendations and guidelines for gastrointestinal ultrasound, Ultraschall Med, 38, e1, 10.1055/s-0042-115853
Atkinson, 2016, WFUMB position paper. Learning gastrointestinal ultrasound: theory and practice, Ultrasound Med Biol, 42, 2732, 10.1016/j.ultrasmedbio.2016.08.026